Concepedia
9
Publications
155
Citations
H-Index
2019
Active since
Affiliations
Bayer (United States)(Current)
Analysis Group (United States)
Pharmerit (United States)
Stanford Medicine
Sreevalsa Appukkuttan is an author at Bayer (United States).
Publications per year
2019–2023
Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
Sandy Srinivas, Ateesha F. Mohamed, Sreevalsa Appukkuttan et al. · Cancer Medicine · 2020 · 31 citations · Full text
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center
Rana R. McKay, Rebecca Silver, Rachel H. Bhak et al. · Prostate Cancer and Prostatic Diseases · 2020 · 22 citations · Full text
Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States
Arif Hussain, Shan Jiang, Della Varghese et al. · BMC Cancer · 2022 · 20 citations · Full text
Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer
Kelli M. Rasmussen, Vikas Patil, Chunyang Li et al. · JAMA Network Open · 2023 · 17 citations · Full text
A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use
Sreevalsa Appukkuttan, Krishna Tangirala, Svetlana Babajanyan et al. · PharmacoEconomics - Open · 2019 · 15 citations · Full text
Rows per page
1–5 of 9